Feasibility of aerosolized colistin in the era of escalating drug-resistant Pseudomonas pneumonia: pressing need for validation clinical trials.
Safdar
Amar
A
D000280:Administration, Inhalation; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003091:Colistin / Q000008:administration & dosage*; D024881:Drug Resistance, Bacterial; D006801:Humans; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D011552:Pseudomonas Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D003091:Colistin
J Aerosol Med Pulm Drug Deliv. 2008 Mar;21(1):71-6
18518833
Int J Antimicrob Agents. 2010 Feb;35(2):194-9
20006471
N Engl J Med. 1962 Apr 12;266:759-62
14008070
Intensive Care Med. 2010 Jul;36(7):1147-55
20397007
J Antimicrob Chemother. 2009 Mar;63(3):534-42
19147523
Am J Respir Crit Care Med. 2002 Nov 15;166(10):1375-81
12406838
Expert Opin Drug Saf. 2009 Jul;8(4):435-49
19538104
Crit Care. 2006;10(4):R123
16934148
J Infect Dis. 1999 May;179(5):1190-6
10191222
Transplantation. 1997 Sep 15;64(5):748-52
9311714
Intensive Care Med. 2009 Jan;35(1):9-29
18989656
Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):253-9
18752007